Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.2.909

Serum Carbohydrate Antigen 19-9 as an Indicator of Liver Metastasis in Colorectal Carcinoma Cases  

Dong, Hang (Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University)
Tang, Jie (Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University)
Li, Long-Hao (Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University)
Ge, Jun (Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University)
Chen, Xin (Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University)
Ding, Jing (Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University)
Men, Hai-Tao (Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University)
Luo, Wu-Xia (Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University)
Du, Yang (Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University)
Li, Cong (Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University)
Zhao, Feng (Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University)
Chen, Ye (Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University)
Cheng, Ke (Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University)
Liu, Ji-Yan (Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.2, 2013 , pp. 909-913 More about this Journal
Abstract
Purpose: The liver is the organ to which colorectal carcinomas (CRCs) most commonly metastasize, and surgical resection has been established as the most effective and potentially curative treatment for CRC with liver metastasis (LM). Therefore, surveillance of LM is vital for improvement of prognosis of CRC patients. In this study, we aimed to explore the potential value of carbohydrate antigen 19-9 (CA 19-9), carcinoembryonic antigen (CEA), and marker enzymes in indicating LM with CRC. Methods: Three groups of eligible patients with metastatic cancers were retrospectively included: CRC patients with LM (CRC-LM) or without LM (CRC-NLM), and non-CRC patients with LM (NCRC-LM). All metastatic lesions were identified by CT or MRI. Data on characteristics of the patients, the primary site, the locations of metastasis, CA 19-9, CEA, and biochemical parameters were collected for analysis. Results: A total of 493 patients were retrospectively included. More alcohol consumption was found in CRC-LM than CRC-NLM. Some biochemical enzymes were found to be significantly higher in groups with LM than without (CRC-LM or NCRC-LM v.s CRC-NLM). Both CEA and CA 19-9 were much higher in CRC-LM than CRC-NLM or NCRC-LM. For CRC patients, CA 19-9, ${\gamma}$-glutamyl transpeptidase, CEA and alcohol consumption were identified as independent factors associated with LM. Conclusion: Our analysis suggested the CA 19-9 might be a potential valuable indicator for LM of CRC in the clinic.
Keywords
Colorectal carcinoma; liver metastasis; CA 19-9; CEA; ${\gamma}$-glutamyl transpeptidase;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Adam R (2003). Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases. Ann Oncol, 14, ii13-6.
2 Assumpcao L, Choti MA, Gleisner AL, et al (2008). Patterns of recurrence following liver resection for colorectal metastases: effect of primary rectal tumor site. Arch Surg, 143, 743-9.   DOI   ScienceOn
3 Ballehaninna UK, Chamberlain RS (2012). The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal. J Gastrointest Oncol, 3, 105-19.
4 Brodt P, Fallavollita L, Bresalier RS, et al (1997). Liver endothelial E-selectin mediates carcinoma cell adhesion and promotes liver metastasis. Int J Cancer, 71, 612-9.   DOI
5 Chevinsky AH (1991). CEA in tumors of other than colorectal origin. Semin Surg Oncol, 7, 162-6.   DOI
6 Gangopadhyay A, Lazure DA, Thomas P (1998). Adhesion of colorectal carcinoma cells to the endothelium is mediated by cytokines from CEA stimulated Kupffer cells. Clin Exp Metastasis, 16, 703-12.   DOI   ScienceOn
7 Gillams AR, Lees WR (2009). Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. Eur Radiol, 19, 1206-13.   DOI   ScienceOn
8 Holt AD, Kim JT, Murrell Z, et al (2006). The role of carcinoembryonic antigen as a predictor of the need for preoperative computed tomography in colon cancer patients. Am Surg, 72, 897-901.
9 Jaeck D, Oussoultzoglou E, Rosso E, et al (2004). A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg, 240, 1037-49.   DOI   ScienceOn
10 Kannagi R, Kitahara A, Itai S, et al (1988). Quantitative and qualitative characterization of human cancer-associated serum glycoprotein antigens expressing epitopes consisting of sialyl or sialyl-fucosyl type 1 chain. Cancer Res, 48, 3856-63.
11 Koike M, Yasui K, Torii A, et al (2000). Prognostic significance of entrapped liver cells in hepatic metastases from colorectal cancer. Ann Surg, 232, 653-7.   DOI   ScienceOn
12 Levy M, Visokai V, Lipska L, et al (2008). Tumor markers in staging and prognosis of colorectal carcinoma. Neoplasma, 55, 138-42.
13 Lin PC, Lin JK, Lin CC, et al (2012). Carbohydrate antigen 19-9 is a valuable prognostic factor in colorectal cancer patients with normal levels of carcinoembryonic antigen and may help predict lung metastasis. Int J Colorectal Dis, 27, 1333-8.   DOI   ScienceOn
14 Locker GY, Hamilton S, Harris J, et al (2006). ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol, 24, 5313-27.   DOI   ScienceOn
15 Lumachi F, Marino F, Orlando R, et al (2012). Simultaneous multianalyte immunoassay measurement of five serum tumor markers in the detection of colorectal cancer. Anticancer Res, 32, 985-8.
16 Maeda M, Nagawa H, Maeda T, et al (1998). Alcohol consumption enhances liver metastasis in colorectal carcinoma patients. Cancer, 83, 1483-8.   DOI
17 Min BS, Lee KY, Park JK, et al (2002). Radiofrequency Ablation of Hepatic Metastasis from Colorectal Cancer; Early Experience. J Korean Surg Soc, 62, 145-9.
18 Mitsuyama Y, Shiba H, Haruki K, et al (2012). Carcinoembryonic antigen and carbohydrate antigen 19-9 are prognostic predictors of colorectal cancer with unresectable liver metastasis. Oncol Lett, 3, 767-71.
19 Nakamori S, Kameyama M, Imaoka S, et al (1993). Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study. Cancer Res, 53, 3632-7.
20 Moolgavkar SH, Holford TR, Levy DT, et al (2012). Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975-2000. J Natl Cancer Inst, 104, 541-8.   DOI
21 Nicolini A, Caciagli M, Zampieri F, et al (1995). Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the Diagnosis of primary colorectal cancer and at its relapse. Cancer Detect Prev, 19, 183-95.
22 Obrador E, Carretero J, Ortega A, et al (2002). gamma-Glutamyl transpeptidase overexpression increases metastatic growth of B16 melanoma cells in the mouse liver. Hepatology, 35, 74-81.   DOI   ScienceOn
23 Petrioli R, Licchetta A, Roviello G, et al (2012). CEA and CA19.9 as early predictors of progression in advanced/metastatic colorectal cancer patients receiving oxaliplatin-based chemotherapy and bevacizumab. Cancer Invest, 30, 65-71.   DOI   ScienceOn
24 Prabasheela B, Baskaran S, Arivazhagan A (2012). Evaluation of alkaline phosphatase in pre and post operative breast cancer patients. Int J Biol Med Res, 3, 1536-7.
25 Rosenberg MA, Feuer EJ, Yu B, et al (2012). Chapter 3: Cohort life tables by smoking status, removing lung cancer as a cause of death. Risk Anal, 32, S25-38.   DOI   ScienceOn
26 Sasaki A, Kawano K, Inomata M, et al (2005). Value of serum carbohydrate antigen 19-9 for predicting extrahepatic metastasis in patients with liver metastasis from colorectal carcinoma. Hepatogastroenterology, 52, 1814-9.
27 Sato H, Usuda N, Kuroda M, et al (2010). Significance of serum concentrations of E-selectin and CA19-9 in the prognosis of colorectal cancer. Jpn J Clin Oncol, 40, 1073-80.   DOI   ScienceOn
28 Van Tilborg AA, Meijerink MR, Sietses C, et al (2011). Long-term results of radiofrequency ablation for unresectable colorectal liver metastases: a potentially curative intervention. Br J Radiol, 84, 556-65.   DOI   ScienceOn
29 Simic T, Dragicevic D, Savic-Radojevic A, et al (2007). Serum gamma glutamyl-transferase is a sensitive but unspecific marker of metastatic renal cell carcinoma. Int J Urol, 14, 289-93.   DOI   ScienceOn
30 Takada A, Ohmori K, Yoneda T, et al (1993). Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res, 53, 354-61.
31 Wang WS, Lin JK, Chiou TJ, et al (2002). CA19-9 as the most significant prognostic indicator of metastatic colorectal cancer. Hepatogastroenterology, 49, 160-4.
32 Yang SH, Lin JK, Lai CR, et al (2004). Risk factors for peritoneal dissemination of colorectal cancer. J Surg Oncol, 87, 167-73.   DOI   ScienceOn